It is predicted that the Radiotherapy Industry will generate massive revenues by 2028
According to The Insight Partners’ research, the global Radiotherapy Market accounted for US$ 6,474.78 million in 2020 and is expected to reach US$ 10,170.80 million by 2028, recording a stellar annual growth rate of 5.9% from 2021 to 2028. Rising prevalence of cancer worldwide and increasing number of conferences and symposiums to boost awareness about radiation therapy are the key parameters aiding the market expansion.
Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPMD00002668/
Health systems across the world
are witnessing a substantial increase in cancer cases. According to the WHO,
over 9.6 million people worldwide died of cancer in 2019. The same data stated
that prostate, lung, colorectal, liver, and stomach cancer occur in men while
breast, colorectal, and cervical cancer instances are common in women. As per
the statistics of Cancer Research UK, around 0.16 million people in the UK
succumb to cancer every year. Such high prevalence of carcinogenic cases drives
the adoption of radiotherapy. In March 2021, the WHO revealed that almost 50%
cancer treatment procedures involve radiotherapy as a part of clinical care and
management.
Over the past few years, a
substantial investment on a global level encouraged the research for early
detection, treatment, and management of cancer. Besides, the education &
research institutes, healthcare authorities, and prominent market players are
actively participating in several conferences and symposiums to impart
knowledge and awareness about radiotherapy and showcase new medical
technologies. In November 2018, Beijing Allcure Medical Technology Co and
Mevion Medical Systems jointly conducted a conference on compact proton therapy
in China. In October 2019, a European symposium was organized by ViewRay Inc to
exhibit the benefits of MRI-guided radiation therapy. Such international
conferences and summits at regular intervals drive the global radiotherapy
market.
Key players dominating the global
radiotherapy market are Siemens Healthineers AG; Accuray Incorporated; Sumitomo
Heavy Industries, Ltd.; Elekta AB; Hitachi, Ltd; Koninklijke Philips N.V.;
Brainlab AG; Protom International; Varian Medical Systems, Inc; Maastro; and
Mevion Medical Systems among others.
Contact Us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment